Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: Unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study

Glenda E. Gray*, Zoe Moodie, Barbara Metch, Peter B. Gilbert, Linda Gail Bekker, Gavin Churchyard, Maphoshane Nchabeleng, Koleka Mlisana, Fatima Laher, Surita Roux, Kathryn Mngadi, Craig Innes, Matsontso Mathebula, Mary Allen, M. Julie McElrath, Michael Robertson, James Kublin, Lawrence Corey

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

94 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: Unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study'. Together they form a unique fingerprint.

Medicine & Life Sciences